Geviti, an end-to-end preventative health and longevity platform, today announced two major additions to its already advanced AI interpretation of healthcare diagnostics. Geviti Genetics, a ...
Immunome, Inc. , a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced the U.S. Food and Drug Administration (FDA or the Agency) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results